House of Lords Business
Show full summary

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Markham on 2 February (HL4910), when the next Therapeutics Clinical Review Panel is scheduled to meet to consider more recent evidence on COVID-19 risk; and who are the members of that panel.  HL5695

Question HL5695: tabled on 20 February 2023 and due for answer by 6 March 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Markham on 2 February (HL4910), when the next Therapeutics Clinical Review Panel is scheduled to meet to consider more recent evidence on COVID-19 risk; and who are the members of that panel.  HL5695
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer